<DOC>
	<DOCNO>NCT02562547</DOCNO>
	<brief_summary>This retrospective data-only study follow phased introduction HEM-AVERT® Perianal Stabilizer routine clinical practice . The investigator aim capitalize introduction HEM-AVERT® Perianal Stabilizer routine clinical practice labor delivery setting hospital Dignity Health - St. Rose , Siena Campus determine whether HEM-AVERT® Perianal Stabilizer reduce frequency Cesarean Section labor delivery .</brief_summary>
	<brief_title>Evaluation Hem-Avert® Perianal Stabilizer Into Routine Clinical Practice</brief_title>
	<detailed_description>The label device study HEM-AVERT® Perianal Stabilizer manufacture Stetrix , Inc . This study sponsor Dignity Health fall within guideline set forth Food Drug Administration 21 CFR Section 812.2 non-significant risk study . The HEM-AVERT® Perianal Stabilizer Class II device accordance FDA regulation 21 CFR 801.109 . Retrospective data collect study reduction c-section rate duration second stage labor . These data may use support application FDA new indication reduce c-section . It also possible second stage labor data may also use support expand labeling .</detailed_description>
	<criteria>Vaginal Births Anticipated nonvaginal birth</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>